Cargando…

Do alternatives to animal experimentation replace preclinical research?

Detalles Bibliográficos
Autores principales:	Mahalmani, Vidya, Prakash, Ajay, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335642/ https://www.ncbi.nlm.nih.gov/pubmed/37313932 http://dx.doi.org/10.4103/ijp.ijp_223_23

Ejemplares similares

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Marathon mice: Researcher view on potential roles in preclinical research
por: Kumaravel, J., et al.
Publicado: (2021)

An urgent need for experimental animal model of autism in drug development
por: Ruhela, Rakesh K, et al.
Publicado: (2015)

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Collaborative research in modern era: Need and challenges
por: Bansal, Seema, et al.
Publicado: (2019)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

Developing and sustaining India's capacity for preclinical drug discovery
por: Lewis, David I., et al.
Publicado: (2018)

Genomic biomarkers: Unveiling the potential for precise cancer therapy response
por: Kaur, Gurjeet, et al.
Publicado: (2023)

Concept of essential medicines and recent updates
por: Gupta, Shreya, et al.
Publicado: (2023)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Social Pharmacology and its impact on clinics
por: Bansal, Seema, et al.
Publicado: (2021)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Connectomics: A pharmacologic viewpoint
por: Harikrishnareddy, Dibbanti, et al.
Publicado: (2018)

Modulation of endocannabinoid system: Success lies in the failures
por: Kumar, Subodh, et al.
Publicado: (2018)

Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: An experimental exploratory study
por: Prakash, Ajay, et al.
Publicado: (2013)

Monkeypox infection: A quick glance
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Changing trends in pharmacology…
por: Medhi, Bikash
Publicado: (2017)

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
por: Kumar, Subodh, et al.
Publicado: (2021)

Experience of an academic institute in importing a novel preclinical drug into India
por: Kumar, M. Praveen, et al.
Publicado: (2017)

Photopharmacology
por: Sarma, Phulen, et al.
Publicado: (2017)

New undergraduate medical education curriculum
por: Mittal, Niti, et al.
Publicado: (2022)

Materiovigilance Programme of India: Current status and way forward
por: Saifuddin, P. K., et al.
Publicado: (2022)

Ecopharmacovigilance: An issue urgently to be addressed
por: Medhi, Bikash, et al.
Publicado: (2012)

Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?
por: Prabha, Praisy K., et al.
Publicado: (2023)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Orphan drugs: Indian perspective
por: Kumar, Harish, et al.
Publicado: (2017)

Cosmetovigilance in India: Need of the day
por: Sarma, Phulen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l6pc2ccn379od9dc3365knl8h5